Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Multiple Myeloma × Caregivers × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 4 Depression 4 Anxiety Disorders 4 Palliative Care 2 Fatigue 2 Caregiver Burden 2 Caregiver 2 Carcinoma, Intraductal, Noninfiltrating 2 Breast Neoplasms 2 Small Cell Lung Carcinoma 1 Sleep Initiation and Maintenance Disorders 1 Pain 1 Multiple Myeloma 1 Lung Neoplasms 1 Glioma 1 Dyspnea 1 Caregivers With a Child Followed up With a Cancer Diagnosis 1 Carcinoma, Non-Small-Cell Lung 1 Cancer Diagnosis 1 Breast Carcinoma In Situ 1

Interventions

Dexamethasone 714 Bortezomib 396 Lenalidomide 383 Cyclophosphamide 305 Melphalan 233 Calcium Dobesilate 208 daratumumab 193 pomalidomide 171 carfilzomib 154 fludarabine phosphate 109 fludarabine 107 Thalidomide 106 Peripheral Blood Stem Cell Transplantation 106 Filgrastim 100 ixazomib 79 Whole-Body Irradiation 74 Mycophenolic Acid 72 Granulocyte Colony-Stimulating Factor 72 Busulfan 71 dexamethasone acetate 69 Tacrolimus 63 Prednisone 58 Cyclosporine 58 dexamethasone 21-phosphate 57 auricularum 53 isatuximab 52 elotuzumab 51 belantamab mafodotin 51 Antilymphocyte Serum 49 Etoposide 45

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07276230 2025-12-29

ENTRAIDANT

Assistance Publique - Hôpitaux de Paris

Phase NA Not yet recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡